| Year |
Citation |
Score |
| 2023 |
Frigault MM, Mithal A, Wong H, Stelte-Ludwig B, Mandava V, Huang X, Birkett J, Johnson AJ, Izumi R, Hamdy AM. Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription. Cancer Research Communications. 3: 2268-79. PMID 37882668 DOI: 10.1158/2767-9764.CRC-23-0219 |
0.392 |
|
| 2022 |
Sher S, Whipp E, Walker J, Zhang P, Beaver L, Williams K, Orwick S, Ravikrishnan J, Walker B, Perry E, Gregory C, Purcell M, Pan A, Yan P, Alinari L, ... ... Izumi R, et al. VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. Leukemia. PMID 36376377 DOI: 10.1038/s41375-022-01758-z |
0.383 |
|
| 2004 |
Dasgupta A, Das S, Izumi R, Venkatesan A, Barat B. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. Fems Microbiology Letters. 234: 189-99. PMID 15135522 DOI: 10.1016/J.Femsle.2004.03.045 |
0.503 |
|
| 2004 |
Izumi RE, Das S, Barat B, Raychaudhuri S, Dasgupta A. A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation. Journal of Virology. 78: 3763-76. PMID 15016896 DOI: 10.1128/Jvi.78.7.3763-3776.2004 |
0.634 |
|
| 2001 |
Izumi RE, Valdez B, Banerjee R, Srivastava M, Dasgupta A. Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Research. 76: 17-29. PMID 11376843 DOI: 10.1016/S0168-1702(01)00240-4 |
0.638 |
|
| Show low-probability matches. |